Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Cancer of Reproductive System: Receptors and Targeting Strategies
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Cancer of Reproductive System: Receptors and Targeting Strategies
Creator
Dandekar, Prajakta
Jain, Ratnesh
Dandekar, ·
Devarajan, P
Devarajan, Padma
Gore, M
Gore, Manish
Indurkar, Abhishek
Indurkar, ·
Jain, ·
Puranik, A
Puranik, Amita
Sonowal, Bismita
Sonowal, ·
Source
PMC
abstract
Carcinogenesis in the different organs of the reproductive system, particularly, prostate, ovarian, and cervical tissues, involves aberrant expression of various physiological receptors belonging to different superfamilies. This chapter provides insights into the physiological receptors that are associated with the genesis, progression, metastasis, management, as well as the prognosis of the cancers of the male and female reproductive systems. It also highlights the structural and binding characteristics of the highly predominant receptors, namely, androgen, estrogen, progesterone, and gonadotropin-releasing hormone (GnRH) receptors, which are overexpressed in these cancers and discusses various strategies to target them.
has issue date
2019-07-25
(
xsd:dateTime
)
bibo:doi
10.1007/978-3-030-29168-6_4
has license
no-cc
sha1sum (hex)
8e379df10bdc373c8494ce5656be5718127c60c9
schema:url
https://doi.org/10.1007/978-3-030-29168-6_4
resource representing a document's title
Cancer of Reproductive System: Receptors and Targeting Strategies
has PubMed Central identifier
PMC7122620
schema:publication
Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis
resource representing a document's body
covid:8e379df10bdc373c8494ce5656be5718127c60c9#body_text
is
schema:about
of
named entity 'Cancer'
named entity 'STRATEGIES'
named entity 'ESTROGEN'
named entity 'PROGNOSIS'
named entity 'ORGANS'
named entity 'VARIOUS'
named entity 'PHYSIOLOGICAL'
named entity 'belonging'
named entity 'male'
named entity 'female'
named entity 'aberrant'
named entity 'metastasis'
named entity 'binding'
named entity 'protein'
named entity 'RFC'
named entity 'HTR1A'
named entity 'angiogenesis'
named entity 'amino-terminal'
named entity 'ligand'
named entity 'contraceptives'
named entity 'EGF'
named entity 'GnRH'
named entity 'molecule'
named entity 'GnRHR'
named entity 'Exemestane'
named entity 'norgestrel'
named entity 'Peroxisome'
named entity 'GnRHR'
named entity 'nuclear translocation'
named entity 'PRAs'
named entity 'Cyclin D1'
named entity 'PRA'
named entity 'sex hormones'
named entity 'biochemical pathways'
named entity 'antineoplastic activity'
named entity 'HTR1A'
named entity 'agonists'
named entity 'activation function'
named entity 'nanoparticles'
named entity 'GnRHR'
named entity 'peptide-based'
named entity 'risk factors'
named entity 'C-17'
named entity 'Vascular endothelial growth factor'
named entity 'hormone'
named entity 'Selenium'
named entity 'p53'
named entity 'solid tumors'
named entity 'estrogen'
named entity 'ERα'
named entity 'mammary gland'
named entity 'hydroxyl groups'
named entity 'prostate cancer'
named entity 'Castration-resistant prostate cancer'
named entity 'translocation'
named entity 'Endothelin-1'
named entity 'ligands'
named entity 'amino acid residues'
named entity 'autocrine'
named entity 'highly conserved'
named entity 'pharmacokinetic profile'
named entity 'PR-B'
named entity 'etonogestrel'
named entity 'combination therapy'
named entity 'tumor'
named entity 'raloxifene'
named entity 'DBD'
named entity 'cathepsin'
named entity 'trimegestone'
named entity 'risk factors'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 10
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software